You just read:

AFFiRiS Announces an Extension of its Existing Alzheimer's Disease Vaccine Development Collaboration With GlaxoSmithKline Triggering a Euro 3.5 Million Payment to AFFiRiS

News provided by

AFFiRiS AG

Feb 28, 2011, 10:59 ET